Estrogen-induced Uterine Abnormalities in TIMP-1 Deficient Mice Are Associated with Elevated Plasmin Activity and Reduced Expression of the Novel Uterine Plasmin Protease Inhibitor Serpinb7
Overview
Reproductive Medicine
Authors
Affiliations
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a multifunctional protein capable of regulating a variety of biological processes in a wide array of tissue and cell types. We have previously demonstrated that TIMP-1 deficient mice exhibit alterations in normal uterine morphology and physiology. Most notably, absence of TIMP-1 is associated with an altered uterine phenotype characterized by profound branching of the uterine lumen and altered adenogenesis. To begin to assess the mechanism by which TIMP-1 may control these uterine events, we utilized steroid-treated ovariectomized wild-type and TIMP-1 null mice exposed to estrogen for 72 hr. Administration of estrogen to TIMP-1 deficient mice resulted in development of an abnormal uterine histo-architecture characterized by increased endometrial gland density, luminal epithelial cell height, and abnormal lumen structure. To determine the mediators which may contribute to the abnormal uterine morphology in the TIMP-1 deficient mice, cDNA microarray analysis was performed. Analysis revealed that expression of two plasmin inhibitors (serpbinb2 and serbinb7) was significantly reduced in the TIMP-1 null mice. Associated with the reduction in expression of these inhibitors was a significant increase in plasmin activity. Localization of the novel uterine serpinb7 revealed that expression was confined to the luminal and glandular epithelial cells. Further, expression of uterine serpinb7 was decreased by estrogen and showed an inverse relationship with plasmin activity. We conclude from these studies that in addition to controlling MMP activity, TIMP-1 may also control activity of serine proteases through modulation of serine protease inhibitors such as serpinb7.
Estradiol-17β-Induced Changes in the Porcine Endometrial Transcriptome In Vivo.
Kaczynski P, Bauersachs S, Baryla M, Goryszewska E, Muszak J, Grzegorzewski W Int J Mol Sci. 2020; 21(3).
PMID: 32019139 PMC: 7037416. DOI: 10.3390/ijms21030890.
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.
Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M Transl Oncol. 2018; 12(1):15-23.
PMID: 30245304 PMC: 6149193. DOI: 10.1016/j.tranon.2018.08.019.
Maternal serum serpin B7 is associated with early spontaneous preterm birth.
Parry S, Zhang H, Biggio J, Bukowski R, Varner M, Xu Y Am J Obstet Gynecol. 2014; 211(6):678.e1-12.
PMID: 24954659 PMC: 4254341. DOI: 10.1016/j.ajog.2014.06.035.
Nothnick W, Graham A, Holbert J, Weiss M PLoS One. 2014; 9(6):e100336.
PMID: 24937656 PMC: 4061076. DOI: 10.1371/journal.pone.0100336.
Nothnick W, Colvin A, Cheng K, Al-Abed Y J Endometr. 2014; 3(3):135-142.
PMID: 24790725 PMC: 4002052.